Ruth Martinez-Sanchez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Journal: Molecular oncology
Published: September 09, 2020
Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer.
Journal: Cancers
Published: September 04, 2020
Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.
Journal: The Journal of clinical investigation
Published: April 27, 2018
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance.
Journal: Scientific reports
Published: January 16, 2018
Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells.
Journal: Scientific reports
Published: June 30, 2017
Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role.
Journal: Journal of lipid research
Published: April 06, 2017
MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer.
Journal: Molecular oncology
Published: February 16, 2017
Lipid metabolism and lung cancer.
Journal: Critical reviews in oncology/hematology
Published: June 28, 2016
The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 06, 2014
Last Updated: 09/26/2026